{{Rsnum
|rsid=3745369
|Gene=RETN
|Chromosome=19
|position=7670589
|Orientation=plus
|GMAF=0.4109
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=RETN
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 34.4 | 51.6 | 14.1
| HCB | 11.1 | 44.4 | 44.4
| JPT | 4.5 | 36.4 | 59.1
| YRI | 15.9 | 36.5 | 47.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 11.1 | 44.4 | 44.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20300528
|Title=A at single nucleotide polymorphism-358 is required for g at -420 to confer the highest plasma resistin in the general Japanese population
|OA=1
}}

{{PMID|18239575}} Analysis of genetic variations in the resistin gene shows no associations with obesity in women.

{{PMID|19074981|OA=1
}} Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring Study.

{{PMID Auto
|PMID=23203410
|Title=Resistin polymorphisms show associations with obesity, but not with bone parameters in men: results from the Odense Androgen Study.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}